microbiota oral (Pending FDA Approval)

Brand and Other Names:
  • Print
Sections

Dosing & Uses

Clostridioides difficile Infection

Pending FDA approval for prevention of Clostridioides difficile infection recurrence

Next:

Pharmacology

Mechanism of Action

Microbiota-based live biotherapeutic delivered orally to provide a broad consortium of diverse microbes to the gut to reduce recurrent C difficile infection after antibiotic treatment

Previous
Next:

Images

No images available for this drug.
Previous
Next:

Patient Handout

A Patient Handout is not currently available for this monograph.
Previous
Medscape prescription drug monographs are based on FDA-approved labeling information, unless otherwise noted, combined with additional data derived from primary medical literature.